| Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer W Ngamcherdtrakul, J Morry, S Gu, DJ Castro, SM Goodyear, ... Advanced functional materials 25 (18), 2646-2659, 2015 | 207 | 2015 |
| Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment M Reda, W Ngamcherdtrakul, MA Nelson, N Siriwon, R Wang, HY Zaidan, ... Nature communications 13 (1), 4261, 2022 | 120 | 2022 |
| Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis J Morry, W Ngamcherdtrakul, S Gu, SM Goodyear, DJ Castro, MM Reda, ... Biomaterials 66, 41-52, 2015 | 73 | 2015 |
| Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery W Ngamcherdtrakul, T Sangvanich, M Reda, S Gu, D Bejan, W Yantasee International journal of nanomedicine, 4015-4027, 2018 | 69 | 2018 |
| PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer M Reda, W Ngamcherdtrakul, S Gu, DS Bejan, N Siriwon, JW Gray, ... Cancer letters 467, 9-18, 2019 | 66 | 2019 |
| Targeted treatment of metastatic breast cancer by PLK1 siRNA delivered by an antioxidant nanoparticle platform J Morry, W Ngamcherdtrakul, S Gu, M Reda, DJ Castro, T Sangvanich, ... Molecular cancer therapeutics 16 (4), 763-772, 2017 | 64 | 2017 |
| In situ tumor vaccination with nanoparticle co‐delivering CpG and STAT3 siRNA to effectively induce whole‐body antitumor immune response W Ngamcherdtrakul, M Reda, MA Nelson, R Wang, HY Zaidan, DS Bejan, ... Advanced Materials 33 (31), 2100628, 2021 | 57 | 2021 |
| Therapeutic siRNA for drug-resistant HER2-positive breast cancer S Gu, Z Hu, W Ngamcherdtrakul, DJ Castro, J Morry, MM Reda, JW Gray, ... Oncotarget 7 (12), 14727, 2016 | 45 | 2016 |
| Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain … W Ngamcherdtrakul, DS Bejan, W Cruz‐Muñoz, M Reda, HY Zaidan, ... Small 18 (11), 2107550, 2022 | 36 | 2022 |
| Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials M Reda, AF Bagley, HY Zaidan, W Yantasee Radiotherapy and Oncology 150, 225-235, 2020 | 32 | 2020 |
| Current development of targeted oligonucleotide-based cancer therapies: perspective on HER2-positive breast cancer treatment W Ngamcherdtrakul, DJ Castro, S Gu, J Morry, M Reda, JW Gray, ... Cancer treatment reviews 45, 19-29, 2016 | 32 | 2016 |
| Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment S Gu, W Ngamcherdtrakul, M Reda, Z Hu, JW Gray, W Yantasee PloS one 13 (6), e0198141, 2018 | 26 | 2018 |
| Lanthanide-loaded nanoparticles as potential fluorescent and mass probes for high-content protein analysis W Ngamcherdtrakul, T Sangvanich, S Goodyear, M Reda, S Gu, ... Bioengineering 6 (1), 23, 2019 | 13 | 2019 |
| Nanotechnology applications in breast cancer immunotherapy R Wang, P Kumar, M Reda, AG Wallstrum, NA Crumrine, ... Small 20 (41), 2308639, 2024 | 12 | 2024 |
| Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model W Ngamcherdtrakul, J Morry, T Sangvanich, M Reda, DS Bejan, ... Scientific Reports 9 (1), 709, 2019 | 9 | 2019 |
| Immunotherapeutic constructs and methods of their use W Yantasee, L Amanda, W Ngamcherdtrakul, R Moataz US Patent 11,235,058, 2022 | 4 | 2022 |
| Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor W Yantasee, R Moataz, W Ngamcherdtrakul US Patent 11,224,573, 2022 | 4 | 2022 |
| Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor W Yantasee, R Moataz, W Ngamcherdtrakul US Patent 11,679,082, 2023 | 3 | 2023 |
| Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain … W Ngamcherdtrakul, DS Bejan, W Cruz‐Muñoz, M Reda, HY Zaidan, ... Small 18 (11), 2270050, 2022 | 3 | 2022 |
| Cancer Nanomedicine: Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer (Adv. Funct. Mater. 18 … W Ngamcherdtrakul, J Morry, S Gu, DJ Castro, SM Goodyear, ... Advanced Functional Materials 25 (18), 2629-2629, 2015 | 3 | 2015 |
